The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy

. 2017 Feb ; 30 (1) : 65-74. [epub] 20160813

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid27522359
Odkazy

PubMed 27522359
DOI 10.1007/s10334-016-0584-x
PII: 10.1007/s10334-016-0584-x
Knihovny.cz E-zdroje

OBJECTIVE: The effects of aging, magnetic field and the voxel localization on measured concentrations of citrate (Cit), creatine (Cr), cholines (Cho) and polyamines (PA) in a healthy prostate were evaluated. MATERIALS AND METHODS: 36 examinations at both 1.5T and 3T imagers of 52 healthy subjects aged 19-71 years were performed with PRESS 3D-CSI sequences (TE = 120 and 145 ms). Concentrations in laboratory units and their ratios to citrate were calculated using the LCModel technique. Absolute concentrations were also obtained after the application of correction coefficients. Statistical analysis was performed using a robust linear mixed effects model. RESULTS: Significant effects of aging, the magnetic field strength and the voxel position in central (CZ) or peripheral (PZ) zones on all measured metabolites were found. The concentrations (mmol/kg wet tissue) including prediction intervals in a range of 20-70 years were found: Cit: 7.9-17.2; Cho: 1.4-1.7; Cr: 2.8-2.5; PA (as spermine): 0.6-2.1 at 3T in CZ. In PZ, the concentrations were higher by about 10 % as compared to CZ. CONCLUSION: Increasing citrate and spermine concentrations with age are significant and correlate well with a recently described increase of zinc in the prostate. These findings should be considered in decision-making if the values obtained from a subject are in the range of control values.

Zobrazit více v PubMed

FEBS Lett. 2001 Apr 6;494(1-2):112-6 PubMed

Magn Reson Med. 1996 Sep;36(3):352-8 PubMed

Magn Reson Med. 2006 Jun;55(6):1257-64 PubMed

Magn Reson Med. 2011 Apr;65(4):914-9 PubMed

Magn Reson Imaging. 2006 Sep;24(7):825-32 PubMed

Mol Cancer. 2006 May 15;5:17 PubMed

J Magn Reson Imaging. 2011 Dec;34(6):1277-84 PubMed

Magn Reson Med. 2005 Jun;53(6):1268-74 PubMed

Radiology. 1996 Mar;198(3):795-805 PubMed

J Magn Reson Imaging. 2015 Oct;42(4):1086-93 PubMed

NMR Biomed. 2014 Jan;27(1):90-9 PubMed

Magn Reson Med. 2015 Jan;73(1):1-12 PubMed

NMR Biomed. 1996 Apr;9(2):59-64 PubMed

Magn Reson Med Sci. 2013 Dec 25;12(4):289-96 PubMed

NMR Biomed. 1998 Oct;11(6):266-72 PubMed

Invest Radiol. 2012 Nov;47(11):624-33 PubMed

PLoS One. 2013 Apr 23;8(4):e62375 PubMed

Magn Reson Med. 1997 Feb;37(2):204-13 PubMed

J Magn Reson. 2000 Dec;147(2):296-330 PubMed

Magn Reson Med. 1993 Dec;30(6):672-9 PubMed

Eur Urol. 2016 Jan;69(1):16-40 PubMed

NMR Biomed. 2014 Apr;27(4):459-67 PubMed

Prostate. 1989;15(4):335-42 PubMed

Radiology. 2007 Nov;245(2):507-16 PubMed

Age (Dordr). 2014 Feb;36(1):167-81 PubMed

Magn Reson Imaging. 1997;15(10):1177-86 PubMed

Comput Methods Programs Biomed. 2013 Oct;112(1):173-88 PubMed

Chemotherapy (Los Angel). 2015 Jun;4(2):null PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...